Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 24, Pages 9646
Publisher
MDPI AG
Online
2020-12-18
DOI
10.3390/ijms21249646
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
- (2020) Yaping Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research
- (2020) Amedeo Lonardo et al. Journal of Clinical Medicine
- Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
- (2020) Alejandra Hernández et al. Cells
- Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
- (2020) Tracey Hurrell et al. Cells
- Concordance of MAFLD and NAFLD diagnostic criteria in “real‐world” data
- (2020) Giovanni Targher LIVER INTERNATIONAL
- FDA rejects NASH drug
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
- (2020) Amélio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- Authors’ response to “Concordance of MAFLD and NAFLD diagnostic criteria in "real‐world" data”
- (2020) Jiaofeng Huang et al. LIVER INTERNATIONAL
- Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars
- (2019) Gemma Sangüesa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis
- (2019) Piero Pingitore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington’s pathology in zQ175 mice
- (2019) Khaled S. Abd-Elrahman et al. Molecular Brain
- Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
- (2019) Rie Ouchi et al. Cell Metabolism
- Liver organoids: from basic research to therapeutic applications
- (2019) Nicole Prior et al. GUT
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis
- (2019) Won-Mook Choi et al. Cell Metabolism
- Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
- (2019) Menso J. Westerouen Van Meeteren et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rodent Models of Nonalcoholic Fatty Liver Disease
- (2019) Fang Zhong et al. DIGESTION
- Ultrasound-based techniques for the diagnosis of liver steatosis
- (2019) Giovanna Ferraioli et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Development of new drugs for the treatment of nonalcoholic steatohepatitis
- (2019) Jie Ting Tang et al. Journal of Digestive Diseases
- Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
- (2019) Guadalupe Garcia-Tsao et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis
- (2018) Abdul M. Oseini et al. Hepatology International
- The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
- (2018) Pengfei Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
- (2018) Pegah Golabi et al. MEDICINE
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- LXRɑ participates in the mTOR/S6K1/SREBP-1c signaling pathway during sodium palmitate-induced lipogenesis in HepG2 cells
- (2018) Youping Zhou et al. Nutrition & Metabolism
- Nonalcoholic Liver Disease in Children and Adolescents
- (2018) Sara Kathryn Smith et al. Clinics in Liver Disease
- Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2018) Zobair M. Younossi et al. TRANSPLANTATION
- Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
- (2018) Amirhossein Sahebkar et al. BMJ Open
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development
- (2017) Matthew D. Davidson et al. Integrative Biology
- Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet
- (2017) Ayae Ikawa-Yoshida et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Liver Graft Susceptibility during Static Cold Storage and Dynamic Machine Perfusion: DCD versus Fatty Livers
- (2017) Andrea Ferrigno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population
- (2017) Raxitkumar Jinjuvadia et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2017) Wenjie Dai et al. MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis
- (2017) Xiaoyan Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
- (2017) Vaishaali Natarajan et al. Biomed Research International
- Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
- (2017) Takako Mukai et al. FEBS Open Bio
- What's in a name? A call to reframe non-communicable diseases
- (2017) Luke N Allen et al. Lancet Global Health
- Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
- (2016) Donghee Kim et al. Clinical Gastroenterology and Hepatology
- Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
- (2016) Camella G. Wilson et al. ENDOCRINOLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation
- (2016) Anna Cleta Croce et al. HEPATOLOGY RESEARCH
- The Natural Course of Non-Alcoholic Fatty Liver Disease
- (2016) Luis Calzadilla Bertot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
- (2016) Petra Hirsova et al. JOURNAL OF LIPID RESEARCH
- Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models
- (2016) Anna C. Croce et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
- (2016) Naim Alkhouri et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters
- (2016) Laura G. Di Pasqua et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Curcumin Protects against Monosodium Glutamate Neurotoxicity and Decreasing NMDA2B and mGluR5 Expression in Rat Hippocampus
- (2016) Rania M. Khalil et al. NEUROSIGNALS
- Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
- (2016) Q Qu et al. Cell Death & Disease
- Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation
- (2016) D. T. Reid et al. PLoS One
- Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma
- (2016) Yao-Yao Zhou et al. Scientific Reports
- Drug-induced fatty liver disease: An overview of pathogenesis and management
- (2015) Sanjaya Satapathy et al. Annals of Hepatology
- The Roles of mTOR Complexes in Lipid Metabolism
- (2015) Alexandre Caron et al. Annual Review of Nutrition
- Palmitate induces insulin resistance in human HepG2 hepatocytes by enhancing ubiquitination and proteasomal degradation of key insulin signaling molecules
- (2015) Megumi Ishii et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population
- (2015) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation
- (2015) Pablo J. Giraudi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Is Obeticholic Acid the Solution to Nonalcoholic Steatohepatitis?
- (2015) Vincent Wai-Sun Wong et al. GASTROENTEROLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease
- (2015) Salih Boga et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Trials of obeticholic acid for non-alcoholic steatohepatitis – Authors' reply
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1
- (2015) Jinbo Han et al. NATURE
- mTOR in Brain Physiology and Pathologies
- (2015) Joël Bockaert et al. PHYSIOLOGICAL REVIEWS
- The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH
- (2015) Varenka J. Barbero-Becerra et al. TOXICOLOGY IN VITRO
- Liver plays a central role in asymmetric dimethylarginine-mediated organ injury
- (2015) Andrea Ferrigno WORLD JOURNAL OF GASTROENTEROLOGY
- Endocrine causes of nonalcoholic fatty liver disease
- (2015) Laura Marino WORLD JOURNAL OF GASTROENTEROLOGY
- De novo lipogenesis in metabolic homeostasis: More friend than foe?
- (2015) Giovanni Solinas et al. Molecular Metabolism
- Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications
- (2014) Shen Yin et al. CELLULAR SIGNALLING
- Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
- (2014) William Peverill et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease
- (2014) Elzafir Elsheikh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
- (2014) Fernando J. Barreyro et al. LIVER INTERNATIONAL
- Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
- (2014) Davide Povero et al. PLoS One
- Experimental models of non-alcoholic fatty liver disease in rats
- (2014) Otto Kucera WORLD JOURNAL OF GASTROENTEROLOGY
- Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway
- (2014) M Jiao et al. Cell Death & Disease
- The Establishment of Metabolic Syndrome Model by Induction of Fructose Drinking Water in Male Wistar Rats
- (2014) Norshalizah Mamikutty et al. Biomed Research International
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- Fatty Acid–Regulated Transcription Factors in the Liver
- (2013) Donald B. Jump et al. Annual Review of Nutrition
- Peroxisome proliferator-activated receptor δ
- (2013) Lazar A. Bojic et al. CURRENT OPINION IN LIPIDOLOGY
- Evolving aspects of liver transplantation for nonalcoholic steatohepatitis
- (2013) Michael Charlton Current Opinion in Organ Transplantation
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Methionine restriction affects oxidative stress and glutathione-related redox pathways in the rat
- (2013) Sreenivasa Maddineni et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
- (2013) Karima Begriche et al. HEPATOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
- (2013) Stacey S. Willard et al. International Journal of Biological Sciences
- Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2013) Kento Imajo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
- (2012) Y. Yilmaz ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
- (2012) Danielle A.A. Hollman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Connecting mTORC1 signaling to SREBP-1 activation
- (2012) Inan Bakan et al. CURRENT OPINION IN LIPIDOLOGY
- Anthropometric and Clinical Factors Associated with Mortality in Subjects with Nonalcoholic Fatty Liver Disease
- (2012) Munkhzul Otgonsuren et al. DIGESTIVE DISEASES AND SCIENCES
- Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis
- (2012) Miroslaw Kornek et al. GASTROENTEROLOGY
- Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
- (2012) Daniel W. Foster JOURNAL OF CLINICAL INVESTIGATION
- Non-alcoholic steatohepatitis: A non-invasive diagnosis by analysis of exhaled breath
- (2012) Froukje J. Verdam et al. JOURNAL OF HEPATOLOGY
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Murine models for pharmacological studies of the metabolic syndrome
- (2012) Lyne Fellmann et al. PHARMACOLOGY & THERAPEUTICS
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
- (2011) Timothy R. Peterson et al. CELL
- In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease
- (2011) N. C. Chavez-Tapia et al. CURRENT MEDICINAL CHEMISTRY
- Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
- (2011) Teoman Dogru et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats
- (2011) Ying-Ying Yang et al. HEPATOLOGY
- Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet
- (2011) Viviane Trak-Smayra et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor α (PPARα)
- (2011) Ana Fernández-Alvarez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis
- (2011) Suzanne E. Mahady et al. JOURNAL OF HEPATOLOGY
- Vitamin E and Cardiovascular Disease
- (2010) Adonis Saremi et al. AMERICAN JOURNAL OF THERAPEUTICS
- Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
- (2010) M. Stepanova et al. GUT
- Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
- (2010) Vlad Ratziu et al. HEPATOLOGY
- High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis
- (2010) Rohit Kohli et al. HEPATOLOGY
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
- (2010) Sander Michel Houten et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
- (2010) Shomit Sengupta et al. NATURE
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty acid transport across the cell membrane: Regulation by fatty acid transporters
- (2010) Robert W. Schwenk et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
- (2009) Kenneth Cusi Clinics in Liver Disease
- Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice
- (2009) Astrid Spruss et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions
- (2009) Michung Yoon PHARMACOLOGICAL RESEARCH
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Regulation of Octn2 Transporter (SLC22A5) by Peroxisome Proliferator Activated Receptor Alpha
- (2008) Tomoji Maeda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet
- (2008) Matthew Wortham et al. DIGESTIVE DISEASES AND SCIENCES
- Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase Response
- (2008) Roxane M. Mansouri et al. ENDOCRINOLOGY
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
- (2008) Scott M. Lippman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
- (2008) Yuko Nakanishi et al. JOURNAL OF AUTOIMMUNITY
- Effect of dietary monosodium glutamate ontransfat-induced nonalcoholic fatty liver disease
- (2008) Kate S. Collison et al. JOURNAL OF LIPID RESEARCH
- Homer Interactions Are Necessary for Metabotropic Glutamate Receptor-Induced Long-Term Depression and Translational Activation
- (2008) J. A. Ronesi et al. JOURNAL OF NEUROSCIENCE
- The Prominent Role of the Liver in the Elimination of Asymmetric Dimethylarginine (ADMA) and the Consequences of Impaired Hepatic Function
- (2008) Milan C. Richir et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
- (2008) Adilson Guilherme et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
- (2007) Elisa Fabbrini et al. GASTROENTEROLOGY
- Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
- (2007) Sander Kersten PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search